Several preclinical studies revealed increased tumor uptake and, hence, better therapeutic efficacy of PSMA radioligands derivatized with the p-iodophenyl moiety as compared to the non-albumin binding reference radioligands 22-25. Here, FOLH1 is linked to neoplasm.